Cancer Innovation Wave
Rod shares insights on the transformative landscape of cancer treatment, emphasizing the shift towards understanding genetic drivers rather than traditional classifications. He highlights the surge in innovation within oncology and immunology, driven by new modalities that enhance drug delivery to challenging tissues. Instead of pursuing countless new modalities, he advocates for refining existing therapies to sustain progress in the industry for the next decade or more.In this clip
From this podcast
Capital Allocators – Inside the Institutional Investment Industry
Rod Wong – Empty Rooms: Innovation in Biotech at RTW (Capital Allocators, EP. 310)
Related Questions